IGF2 and hepatocellular carcinoma: More recently, it was shown that 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) was able to trigger the onset of hepatoma in a rodent model via specific induction of IGF2 transcription, concomitant with the increase in C/EBPβ promoter activity.